Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1.

Xiang Y, Ma L, Wu W, Liu W, Li Y, Zhu X, Wang Q, Ma J, Cao M, Wang Q, Yao X, Yang L, Wubuli A, Merle C, Milligan P, Mao Y, Gu J, Xin X.

PLoS One. 2014 Jan 23;9(1):e85905. doi: 10.1371/journal.pone.0085905. eCollection 2014.

PMID:
24465778
[PubMed - in process]
Free PMC Article
2.

Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.

Teixeira RL, Morato RG, Cabello PH, Muniz LM, Moreira Ada S, Kritski AL, Mello FC, Suffys PN, Miranda AB, Santos AR.

Mem Inst Oswaldo Cruz. 2011 Sep;106(6):716-24.

PMID:
22012226
[PubMed - indexed for MEDLINE]
Free Article
3.

Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis.

Sun F, Chen Y, Xiang Y, Zhan S.

Int J Tuberc Lung Dis. 2008 Sep;12(9):994-1002. Review.

PMID:
18713495
[PubMed - indexed for MEDLINE]
4.

CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study.

Tang SW, Lv XZ, Zhang Y, Wu SS, Yang ZR, Xia YY, Tu DH, Deng PY, Ma Y, Chen DF, Zhan SY.

J Clin Pharm Ther. 2012 Oct;37(5):588-93. doi: 10.1111/j.1365-2710.2012.01334.x. Epub 2012 Feb 15.

PMID:
22335459
[PubMed - indexed for MEDLINE]
5.

NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients.

An HR, Wu XQ, Wang ZY, Zhang JX, Liang Y.

Clin Exp Pharmacol Physiol. 2012 Jun;39(6):535-43. doi: 10.1111/j.1440-1681.2012.05713.x.

PMID:
22506592
[PubMed - indexed for MEDLINE]
6.

Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.

Singla N, Gupta D, Birbian N, Singh J.

Tuberculosis (Edinb). 2014 May;94(3):293-8. doi: 10.1016/j.tube.2014.02.003. Epub 2014 Feb 15.

PMID:
24637014
[PubMed - in process]
7.

NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis.

Wang PY, Xie SY, Hao Q, Zhang C, Jiang BF.

Int J Tuberc Lung Dis. 2012 May;16(5):589-95. doi: 10.5588/ijtld.11.0377. Epub 2012 Mar 8. Review.

PMID:
22409928
[PubMed - indexed for MEDLINE]
8.

Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.

Costa GN, Magno LA, Santana CV, Konstantinovas C, Saito ST, Machado M, Di Pietro G, Bastos-Rodrigues L, Miranda DM, De Marco LA, Romano-Silva MA, Rios-Santos F.

Mol Diagn Ther. 2012 Aug 1;16(4):241-50. doi: 10.2165/11634480-000000000-00000.

PMID:
22788240
[PubMed - indexed for MEDLINE]
9.

Relationship of NAT2, CYP2E1 and GSTM1/GSTT1 polymorphisms with mild elevation of liver enzymes in Brazilian individuals under anti-tuberculosis drug therapy.

Forestiero FJ, Cecon L, Hirata MH, de Melo FF, Cardoso RF, Cerda A, Hirata RD.

Clin Chim Acta. 2013 Jan 16;415:215-9. doi: 10.1016/j.cca.2012.10.030. Epub 2012 Oct 22.

PMID:
23099118
[PubMed - indexed for MEDLINE]
Free Article
10.

Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis.

Cai Y, Yi J, Zhou C, Shen X.

PLoS One. 2012;7(10):e47769. doi: 10.1371/journal.pone.0047769. Epub 2012 Oct 17.

PMID:
23082213
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis.

Lee SW, Chung LS, Huang HH, Chuang TY, Liou YH, Wu LS.

Int J Tuberc Lung Dis. 2010 May;14(5):622-6.

PMID:
20392357
[PubMed - indexed for MEDLINE]
12.

Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis.

Cho HJ, Koh WJ, Ryu YJ, Ki CS, Nam MH, Kim JW, Lee SY.

Tuberculosis (Edinb). 2007 Nov;87(6):551-6.

PMID:
17950035
[PubMed - indexed for MEDLINE]
13.

Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India.

Gupta VH, Amarapurkar DN, Singh M, Sasi P, Joshi JM, Baijal R, Ramegowda PH, Amarapurkar AD, Joshi K, Wangikar PP.

J Gastroenterol Hepatol. 2013 Aug;28(8):1368-74. doi: 10.1111/jgh.12194.

PMID:
23875638
[PubMed - indexed for MEDLINE]
14.

Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.

Ben Mahmoud L, Ghozzi H, Kamoun A, Hakim A, Hachicha H, Hammami S, Sahnoun Z, Zalila N, Makni H, Zeghal K.

Pathol Biol (Paris). 2012 Oct;60(5):324-30. doi: 10.1016/j.patbio.2011.07.001.

PMID:
21856096
[PubMed - indexed for MEDLINE]
15.

The roles of GSTM1 and GSTT1 null genotypes and other predictors in anti-tuberculosis drug-induced liver injury.

Monteiro TP, El-Jaick KB, Jeovanio-Silva AL, Brasil PE, Costa MJ, Rolla VC, de Castro L.

J Clin Pharm Ther. 2012 Dec;37(6):712-8. doi: 10.1111/j.1365-2710.2012.01368.x. Epub 2012 Jul 30.

PMID:
22845549
[PubMed - indexed for MEDLINE]
16.

CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.

Vuilleumier N, Rossier MF, Chiappe A, Degoumois F, Dayer P, Mermillod B, Nicod L, Desmeules J, Hochstrasser D.

Eur J Clin Pharmacol. 2006 Jun;62(6):423-9. Epub 2006 Apr 27.

PMID:
16770646
[PubMed - indexed for MEDLINE]
17.

Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.

Hirvonen A, Saarikoski ST, Linnainmaa K, Koskinen K, Husgafvel-Pursiainen K, Mattson K, Vainio H.

J Natl Cancer Inst. 1996 Dec 18;88(24):1853-6.

PMID:
8961976
[PubMed - indexed for MEDLINE]
Free Article
18.

Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China.

Shang P, Xia Y, Liu F, Wang X, Yuan Y, Hu D, Tu D, Chen Y, Deng P, Cheng S, Zhou L, Ma Y, Zhu L, Gao W, Wang H, Chen D, Yang L, He P, Wu S, Tang S, Lv X, Shu Z, Zhang Y, Yang Z, Chen Y, Li N, Sun F, Li X, He Y, Garner P, Zhan S.

PLoS One. 2011;6(7):e21836. doi: 10.1371/journal.pone.0021836. Epub 2011 Jul 5.

PMID:
21750735
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.

Song DK, Xing DL, Zhang LR, Li ZX, Liu J, Qiao BP.

Cancer Detect Prev. 2009;32(5-6):416-23. doi: 10.1016/j.cdp.2009.02.003. Epub 2009 Mar 20.

PMID:
19303722
[PubMed - indexed for MEDLINE]
20.

N-acetyl transferase 2 and cytochrome P450 2E1 genes and isoniazid-induced hepatotoxicity in Brazilian patients.

Santos NP, Callegari-Jacques SM, Ribeiro Dos Santos AK, Silva CA, Vallinoto AC, Fernandes DC, de Carvalho DC, Santos SE, Hutz MH.

Int J Tuberc Lung Dis. 2013 Apr;17(4):499-504. doi: 10.5588/ijtld.12.0645. Epub 2013 Jan 31.

PMID:
23394127
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk